Skip to search formSkip to main contentSkip to account menu

balapiravir

Known as: 4-Amino-1-(4-C-Azido-2',3',5'-Tri-O-(2-Methylpropanoyl)-Beta-D-Ribofuranosyl)Pyrimidin- 2(1H)-One, Cytidine, 4'-C-Azido-, 2',3',5'-Tris(2-Methylpropanoate) 
An orally administered prodrug with activity against the hepatitis C virus (HCV). Balapiravir is a tri-isobutyrate ester prodrug of R1479, a… 
National Institutes of Health

Related topics

Related topics

3 relations
Balapiravir Hydrochloride

Broader (1)

Nucleosides

Narrower (1)

R1626

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Discovery and Clinical Evaluation of the Nucleoside Analog Balapiravir (R1626) for the Treatment of HCV Infection
2010
2010
778 PHASE IIB STUDY OF BALAPIRAVIR (RG1626; NUCLEOSIDE ANALOGUE INHIBITOR OF HCV POLYMERASE) PLUS PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN FOR CHC GENOTYPE 1: FINAL RESULTS
2009
2009
Chemical stability of 4′-azidocytidine and its prodrug balapiravir
Background: R1479, a 4′-azidocytidine nucleoside analog, was developed for the treatment of Hepatitis C virus infection… 
1994
1994
Interactions of 2'-modified azido- and haloanalogs of deoxycytidine 5'-triphosphate with the anaerobic ribonucleotide reductase of Escherichia coli.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)